Two Sigma Investments
VRNA

Two Sigma Investments’s Verona Pharma VRNA Stock Holding History

Two Sigma Investments’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,997
Closed -$5.34M – 4459
2025
Q3 		$5.34M Sell
49,997
-300,545
-86% -$31.4M 0.01% 1408
2025
Q2 		$33.2M Buy
350,542
+271,331
+343% +$20.1M 0.06% 388
2025
Q1 		$5.03M Sell
79,211
-72,893
-48% -$4.36M 0.01% 1127
2024
Q4 		$7.06M Buy
152,104
+82,166
+117% +$3.08M 0.02% 915
2024
Q3 		$2.01M Buy
69,938
+54,141
+343% +$1.33M ﹤0.01% 1676
2024
Q2 		$228K Sell
15,797
-126,017
-89% -$1.84M ﹤0.01% 2693
2024
Q1 		$2.28M Buy
141,814
+94,577
+200% +$1.64M 0.01% 1390
2023
Q4 		$939K Buy
47,237
+10,377
+28% +$153K ﹤0.01% 2118
2023
Q3 		$601K Sell
36,860
-333,815
-90% -$6.43M ﹤0.01% 2199
2023
Q2 		$7.84M Sell
370,675
-34,306
-8% -$732K 0.02% 739
2023
Q1 		$8.13M Sell
404,981
-119,550
-23% -$2.58M 0.02% 671
2022
Q4 		$13.7M Buy
524,531
+163,981
+45% +$2.18M 0.04% 456
2022
Q3 		$3.69M Buy
+360,550
New +$3.04M 0.01% 871

Other funds holding VRNA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Two Sigma Investments's VRNA Position: Q4 2025 in Review

Two Sigma Investments sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 49,997 shares — an estimated $5.34M sold.

Two Sigma Investments first reported a position in VRNA in Q3 2022 and held it in 13 quarters. The position peaked at $33.2M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

  • Two Sigma Investments reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 49,997 Verona Pharma shares in Q4 2025, an estimated $5.34M.
  • Two Sigma Investments first reported a position in Verona Pharma in Q3 2022 and held it in 13 quarters.
  • Two Sigma Investments's Verona Pharma position peaked at $33.2M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.